c.tulloch
TL2 Moderator · Bochum
Contributes reviews on supplier material. Based in Bochum.
Joined 6 July 2025 · last posted 3d · groups: newcomer-guides
101 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #100 · Analytics › COA interpretation · 25 Jul 2026 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #25 · Sourcing › Payments · 23 Jul 2026 · 4 likes I read post #23 twice before replying, because I had assumed the opposite. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails,…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #19 · Analytics › Impurities & related substances · 21 Jul 2026 · 0 likes Worth separating two things that post #15 runs together. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #47 · Start Here › Welcome · 16 Jul 2026 · 0 likes Worth separating two things that post #43 runs together. Trust levels accumulate over time and they give you access to small things like the ability to edit your own…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #42 · Compounds › Retatrutide · 11 Jul 2026 · 29 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Pages past their review date, listed — does this still hold? Replied, post #46 · Meta › Wiki maintenance · 10 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How much context is too much context in a first post? Replied, post #8 · Start Here › How to Ask · 4 Jul 2026 · 3 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #13 · Compounds › Repair & healing peptides · 4 Jul 2026 · 10 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
About the Receptor biology category Replied, post #9 · Pharmacology › Receptor biology · 2 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #43 · Clinical › Prescriber conversations · 30 Jun 2026 · 0 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #61 · Compounds › Tirzepatide · 26 Jun 2026 · 14 likes Worth separating two things that post #57 runs together. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #38 · Start Here › How to Ask · 13 Jun 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Reading a trial's population section before its results Replied, post #103 · Evidence › Trials · 9 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #27 · Analytics › Method validation · 8 Jun 2026 · 3 likes Coming back to post #25, because the follow-up matters more than the original answer. Why two laboratories may disagree: after validating the same method, they may…
-
Racemisation and why it is invisible to a mass measurement Replied, post #3 · Analytics › Impurities & related substances · 8 Jun 2026 · 13 likes This follows post #2 rather than contradicting it. Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #84 · Practice › Storage & stability · 7 Jun 2026 · 0 likes Coming back to post #82, because the follow-up matters more than the original answer. Published stability data applies specifically to the formulation studied, under…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #57 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #75 · Evidence › Journal club · 3 Jun 2026 · 0 likes This follows post #72 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
What a certificate commits its issuer to — the long version Replied, post #9 · Analytics › COA interpretation · 23 May 2026 · 11 likes This follows post #6 rather than contradicting it. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The…
-
Request declined, with reasoning — what changed since Replied, post #38 · Meta › Feature requests · 11 May 2026 · 2 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #134 · Pharmacology › Pharmacokinetics · 8 May 2026 · 22 likes Coming back to post #132, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
I have no scientific background — can I still follow the analytics categories? Started this topic · Start Here › Welcome · 7 May 2026 · 7 likes The question in the title: I have no scientific background — can I still follow the analytics categories? I will give what I have already checked below so nobody…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Started this topic · Pharmacology › Pharmacokinetics · 6 May 2026 · 60 likes Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. I would…
-
Five questions in one post gets you one answer — how to split them Replied, post #71 · Start Here › How to Ask · 3 May 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Managing an unplanned gap in supply Replied, post #102 · Access › Shortages · 18 Apr 2026 · 1 like Coming back to post #100, because the follow-up matters more than the original answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #39 · Compounds › Repair & healing peptides · 18 Apr 2026 · 10 likes Coming back to post #37, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Follow-up: State-level differences that actually matter Replied, post #49 · Regional › North America · 6 Apr 2026 · 22 likes Worth separating two things that post #45 runs together. Regional variation in North America: access differs substantially by US state and Canadian province. Postcode…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #53 · Practice › Administration · 5 Apr 2026 · 4 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #11 · Sourcing › Vendor reports · 2 Apr 2026 · 9 likes On post #7 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Grapefruit: why this class is not the class that cares Replied, post #88 · Practice › Interactions · 28 Mar 2026 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
The "under review" status pill and when a moderator applies it Replied, post #13 · Evidence › Preprints · 9 Mar 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #25 · Research Methods › N-of-1 designs · 1 Mar 2026 · 0 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
[2026 update] What a good consultation looks like from the other side Replied, post #18 · Clinical › Prescriber conversations · 26 Feb 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #64 · Practice › Dosing & titration · 18 Feb 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #70 · Sourcing › Vendor reports · 15 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #30 · Analytics › Mass spectrometry · 7 Feb 2026 · 28 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Trifluoroacetate content and its consequences Replied, post #103 · Analytics › Impurities & related substances · 7 Feb 2026 · 19 likes post #102 answers the question as asked. The question underneath it is different. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #45 · Practice › Interactions · 6 Feb 2026 · 0 likes This follows post #42 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #42 · Practice › Interactions · 28 Jan 2026 · 19 likes Worth separating two things that post #38 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #95 · Sourcing › Independent verification · 25 Jan 2026 · 5 likes post #94 is right about the mechanism and I think understates the practical bit. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #61 · Clinical › Special populations · 24 Jan 2026 · 3 likes On post #57 — agreed on the reasoning, with one qualification. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #82 · Clinical › Special populations · 22 Jan 2026 · 9 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Heterogeneity as information rather than as a nuisance Replied, post #72 · Evidence › Meta-analyses · 22 Jan 2026 · 19 likes post #71 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #36 · Devices › Pens & autoinjectors · 4 Jan 2026 · 23 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Adsorption to container surfaces and to plastics Started this topic · Pharmacology › Formulation chemistry · 26 Dec 2025 · 37 likes On the subject in the title: Adsorption to container surfaces and to plastics Working notes rather than a conclusion. A documentation question rather than an analytical…
-
Run-in periods and the population they select Replied, post #36 · Evidence › Trials · 16 Dec 2025 · 11 likes Picking up post #33: that is the part I would want checked first. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #93 · Compounds › Oral incretins · 15 Dec 2025 · 1 like PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Tracking a preprint to publication: a worked example Replied, post #82 · Evidence › Preprints · 8 Dec 2025 · 0 likes Picking up post #79: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #64 · Compounds › Other compounds · 25 Nov 2025 · 0 likes I read post #62 twice before replying, because I had assumed the opposite. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not…
-
Robustness: the parameters worth deliberately varying Replied, post #12 · Analytics › Method validation · 21 Nov 2025 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #94 · Compounds › Tirzepatide · 17 Nov 2025 · 29 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
[2026 update] What steady state means for the decision to escalate Replied, post #90 · Practice › Dosing & titration · 14 Nov 2025 · 3 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #9 · Clinical › Bloodwork · 7 Nov 2025 · 17 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Payment mechanics and the recovery options that do not exist Replied, post #50 · Sourcing › Payments · 21 Oct 2025 · 19 likes Picking up post #47: that is the part I would want checked first. Documentation and tax implications: payments you make for compounds might have implications for tax…
-
Second pass at: The mass-error checker and its intended scope Replied, post #41 · Data & Tools › Calculators · 18 Oct 2025 · 2 likes post #40 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Personal import allowances, compared — a second dataset Replied, post #9 · Access › International · 13 Oct 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Waist circumference technique and its repeatability Replied, post #5 · Outcomes › Progress reports · 7 Oct 2025 · 23 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #16 · Nutrition & Training › Protein & intake · 6 Oct 2025 · 12 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #3 · Evidence › Trials · 29 Sep 2025 · 30 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Titles that describe the question, not the situation — what changed since Replied, post #29 · Start Here › How to Ask · 20 Sep 2025 · 2 likes This follows post #26 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #81 · Clinical › Special populations · 14 Sep 2025 · 4 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #8 · Analytics › Home & field testing · 8 Sep 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #25 · Evidence › Journal club · 17 Aug 2025 · 20 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
High-resolution MS on aggregates and what it can see Replied, post #26 · Analytics › Mass spectrometry · 20 Jul 2025 · 20 likes Coming back to post #24, because the follow-up matters more than the original answer. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #84 · Clinical › Comorbidities · 6 Jul 2025 · 21 likes Picking up post #81: that is the part I would want checked first. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside…
-
What a 2 ppm match establishes, and what it does not Replied, post #28 · Analytics › Mass spectrometry · 25 Jun 2025 · 1 like Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #31 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 30 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Pre-registering a personal experiment, seriously Replied, post #110 · Research Methods › N-of-1 designs · 3 Jun 2025 · 6 likes I read post #108 twice before replying, because I had assumed the opposite. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about…
-
A claim built entirely on a subgroup analysis Replied, post #59 · Evidence › Study critique · 27 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #94 · Compounds › Tirzepatide · 26 May 2025 · 5 likes Worth separating two things that post #90 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #44 · Research Methods › N-of-1 designs · 22 May 2025 · 20 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #107 · Compounds › Semaglutide · 7 May 2025 · 22 likes Worth separating two things that post #103 runs together. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #50 · Compounds › Secretagogues & GH axis · 26 Apr 2025 · 11 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Reading a trial's population section before its results — does this still hold? Replied, post #39 · Evidence › Trials · 25 Apr 2025 · 1 like Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Scheduled maintenance and what will be unavailable Replied, post #111 · Meta › Announcements · 16 Apr 2025 · 29 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #48 · Practice › Interactions · 15 Apr 2025 · 7 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #127 · Access › International · 27 Mar 2025 · 1 like On post #123 — agreed on the reasoning, with one qualification. Customs and import outcomes: different routes have different seizure rates. Some countries are stricter…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #33 · Wellbeing › Mental health · 22 Mar 2025 · 2 likes Picking up post #30: that is the part I would want checked first. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status…
-
UK access routes, dated and sourced — a second dataset Replied, post #50 · Regional › UK & Ireland · 14 Mar 2025 · 23 likes Worth separating two things that post #46 runs together. Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #4 · Wellbeing › Mental health · 13 Mar 2025 · 2 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #66 · Devices › Cold chain · 12 Mar 2025 · 16 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #25 · Access › Pricing · 5 Mar 2025 · 4 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Consistent declarations and why they matter more than clever ones Replied, post #98 · Sourcing › Logistics · 27 Feb 2025 · 12 likes On post #94 — agreed on the reasoning, with one qualification. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #30 · Compounds › Oral incretins · 16 Feb 2025 · 8 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Second pass at: A history of disordered eating: proceeding carefully Started this topic · Wellbeing › Mental health · 26 Jan 2025 · 1 like On the subject in the title: Second pass at: A history of disordered eating: proceeding carefully Working notes rather than a conclusion. General question, not a…
-
Identical chromatograms across two different lots Replied, post #78 · Sourcing › Red flags · 18 Jan 2025 · 11 likes On post #74 — agreed on the reasoning, with one qualification. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and…
-
Oxidation pathways for methionine and tryptophan Replied, post #52 · Analytics › Impurities & related substances · 30 Dec 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #5 · Evidence › Meta-analyses · 11 Dec 2024 · 2 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Why "any advice?" is the least effective ending for a post Replied, post #104 · Start Here › How to Ask · 4 Dec 2024 · 0 likes On post #100 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Revisiting: Moderation log format change Replied, post #50 · Meta › Announcements · 1 Dec 2024 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #96 · Clinical › Prescriber conversations · 9 Nov 2024 · 30 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #14 · Meta › Wiki maintenance · 21 Oct 2024 · 7 likes This follows post #11 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #114 · Access › Shortages · 13 Oct 2024 · 15 likes post #113 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Requesting a page: what makes a good request — what changed since Replied, post #79 · Documentation › Wiki requests · 11 Oct 2024 · 1 like On post #75 — agreed on the reasoning, with one qualification. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues,…
-
Chronic kidney disease and the FLOW result — a second dataset Started this topic · Clinical › Comorbidities · 8 Oct 2024 · 11 likes Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. General question, not a…
-
Promotion criteria, and the one that stops most nominations Replied, post #70 · Documentation › Doc review · 25 Sep 2024 · 28 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 11 Aug 2024 · 1 like Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Guidelines revision: what changed and why Replied, post #46 · Meta › Announcements · 26 Jul 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #60 · Evidence › Journal club · 24 Jul 2024 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #16 · Compounds › Retatrutide · 16 Jul 2024 · 3 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
The mass-error checker and its intended scope Replied, post #3 · Data & Tools › Calculators · 19 May 2024 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…